| |
| |
|
| Insider
Information: |
Parini Michael |
| Relationship: |
EVP, Chief Adm, Leg & ... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
30,837 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,895,504 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,837 |
|
|
| Total
Value |
$14,895,504 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Adm, Leg & ... |
2021-02-25 |
30,837 |
2016-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
115 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-07-05 |
4 |
AS |
$168.38 |
$715,615 |
D/D |
(4,250) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-07-12 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
41,734 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-07-12 |
4 |
AS |
$175.02 |
$371,918 |
D/D |
(2,125) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-08-03 |
4 |
AS |
$174.20 |
$405,886 |
D/D |
(2,330) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-08-03 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
41,939 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-10-04 |
4 |
OE |
$122.45 |
$520,413 |
D/D |
4,250 |
43,859 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-10-04 |
4 |
AS |
$191.58 |
$814,215 |
D/D |
(4,250) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-10-12 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
41,734 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-10-12 |
4 |
AS |
$177.20 |
$376,550 |
D/D |
(2,125) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-11-05 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
41,939 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-11-05 |
4 |
AS |
$172.08 |
$400,946 |
D/D |
(2,330) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-11-15 |
4 |
AS |
$163.75 |
$14,738 |
D/D |
(90) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-01-04 |
4 |
OE |
$122.45 |
$520,413 |
D/D |
4,250 |
43,859 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-01-04 |
4 |
AS |
$165.90 |
$705,075 |
D/D |
(4,250) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-01-14 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
41,734 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-01-14 |
4 |
AS |
$186.71 |
$396,759 |
D/D |
(2,125) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-01-22 |
4 |
OE |
$155.57 |
$570,631 |
D/D |
3,668 |
43,277 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-01-22 |
4 |
AS |
$195.00 |
$715,260 |
D/D |
(3,668) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-02-01 |
4 |
AS |
$190.92 |
$658,674 |
D/D |
(3,450) |
36,159 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-02-04 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
38,489 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-02-04 |
4 |
AS |
$189.19 |
$440,813 |
D/D |
(2,330) |
36,159 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,604 |
52,763 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-02-11 |
4 |
AS |
$179.48 |
$2,187,190 |
D/D |
(12,136) |
40,627 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-02-19 |
4 |
AS |
$186.79 |
$1,051,585 |
D/D |
(5,624) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-04-16 |
4 |
OE |
$90.29 |
$712,279 |
D/D |
6,375 |
37,128 |
0 |
- |
|
115 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
